Genetic engineering platforms and research translated honestly.
Population genomics is the large-scale application of genomic technologies to study populations of individuals, a definition maintained by the National Human Genome Research Institute. The scale is no longer theoretical: per NIH's June 30, 2026 announcement, the All of Us Research Program now…
Genomic data privacy in the United States rests on a patchwork: the Genetic Information Nondiscrimination Act of 2008 bars the use of genetic information in health insurance and employment decisions, while NIH policy governs federally funded research data. Between them sit large uncovered areas…
Genetic testing oversight in the United States has returned to its pre-2024 framework: on September 19, 2025, the FDA reverted 21 CFR 809.3(a) to its prior text, after a federal district court vacated the 2024 laboratory-developed-test rule on March 31, 2025, per the FDA’s policy page. Oversight…
The FDA has cleared GenEditBio's investigational new drug application for GEB-101, an in vivo genome-editing therapy for TGFBI corneal dystrophy, the company announced on January 5, 2026. The clearance enables the Phase 1/2 CLARITY trial, in which participants receive a single intrastromal…
Gene synthesis is the industrial process of building specified DNA sequences base by base, without a natural template. Short fragments are made by phosphoramidite chemistry, assembled into genes enzymatically, and error-corrected before sequencing verification, and in the United States…